Aberdeen Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $143M | Buy |
|
|||||
|
2025
Q2 | $144M | Buy |
|
|||||
|
2025
Q1 | $174M | Sell |
|
|||||
|
2024
Q4 | $168M | Sell |
|
|||||
|
2024
Q3 | $155M | Sell |
|
|||||
|
2024
Q2 | $144M | Sell |
|
|||||
|
2024
Q1 | $202M | Sell |
|
|||||
|
2023
Q4 | $200M | Buy |
|
|||||
|
2023
Q3 | $177M | Sell |
|
|||||
|
2023
Q2 | $206M | Buy |
|
|||||
|
2023
Q1 | $217M | Sell |
|
|||||
|
2022
Q4 | $232M | Sell |
|
|||||
|
2022
Q3 | $230M | Buy |
|
|||||
|
2022
Q2 | $224M | Buy |
|
|||||
|
2022
Q1 | $202M | Sell |
|
|||||
|
2021
Q4 | $190M | Sell |
|
|||||
|
2021
Q3 | $288M | Sell |
|
|||||
|
2021
Q2 | $365M | Buy |
|
|||||
|
2021
Q1 | $342M | Buy |
|
|||||
|
2020
Q4 | $291M | Buy |
|
|||||
|
2020
Q3 | $281M | Buy |
|
|||||
|
2020
Q2 | $269M | Sell |
|
|||||
|
2020
Q1 | $268M | Buy |
|
|||||
|
2019
Q4 | $307M | Buy |
|
|||||
|
2019
Q3 | $230M | Sell |
|
|||||
|
2019
Q2 | $222M | Buy |
|
|||||
|
2019
Q1 | $189M | Buy |
|
|||||
|
2018
Q4 | $35M | Buy |
|
|||||
|
2018
Q3 | $33.1M | Buy |
|
|||||
|
2018
Q2 | $26.9M | Buy |
|
|||||
|
2018
Q1 | $25M | Sell |
|
|||||
|
2017
Q4 | $25.5M | Sell |
|
|||||
|
2017
Q3 | $27.3M | Buy |
|